Intravascular Ultrasound Systems (IVUS) - Medical Devices Pipeline Assessment, 2018

Intravascular Ultrasound Systems (IVUS) - Medical Devices Pipeline Assessment, 2018

Summary

The author's Medical Devices sector report, “Intravascular Ultrasound Systems (IVUS) - Medical Devices Pipeline Assessment, 2018" provides an overview of Intravascular Ultrasound Systems (IVUS) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Intravascular Ultrasound Systems (IVUS) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by the author's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Intravascular Ultrasound Systems (IVUS) under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Intravascular Ultrasound Systems (IVUS) and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment/industry

Reasons to buy

The report enables you to:

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Intravascular Ultrasound Systems (IVUS) under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product’s current stage of development, territory and estimated launch date

1 Table of Contents

2 Introduction

2.1 Intravascular Ultrasound Systems (IVUS) Overview

3 Products under Development

3.1 Intravascular Ultrasound Systems (IVUS) - Pipeline Products by Stage of Development
3.2 Intravascular Ultrasound Systems (IVUS) - Pipeline Products by Segment
3.3 Intravascular Ultrasound Systems (IVUS) - Pipeline Products by Territory
3.4 Intravascular Ultrasound Systems (IVUS) - Pipeline Products by Regulatory Path
3.5 Intravascular Ultrasound Systems (IVUS) - Pipeline Products by Estimated Approval Date

4 Intravascular Ultrasound Systems (IVUS) - Pipeline Products under Development by Companies

4.1 Intravascular Ultrasound Systems (IVUS) Companies - Pipeline Products by Stage of Development
4.2 Intravascular Ultrasound Systems (IVUS) - Pipeline Products by Stage of Development

5 Intravascular Ultrasound Systems (IVUS) Companies and Product Overview

5.1 Arbor Ultrasound Technologies, LLC (Inactive) Company Overview
5.1.1 Arbor Ultrasound Technologies, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.2 Biosense Webster Inc Company Overview
5.2.1 Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Boston Scientific Corp Company Overview
5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.4 Covidien plc Company Overview
5.4.1 Covidien plc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Georgia Institute of Technology Company Overview
5.5.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
5.6 North Carolina State University Company Overview
5.6.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
5.7 OCT Medical Imaging Inc Company Overview
5.7.1 OCT Medical Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 RadioSon Corporation Company Overview
5.8.1 RadioSon Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.9 SIBUS Medical Inc (Inactive) Company Overview
5.9.1 SIBUS Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.10 Soundpipe LLC Company Overview
5.10.1 Soundpipe LLC Pipeline Products & Ongoing Clinical Trials Overview
5.11 Terumo Corp Company Overview
5.11.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
5.12 University of Oxford Company Overview
5.12.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
5.13 University of Texas at Austin Company Overview
5.13.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview
5.14 Volcano Corp Company Overview
5.14.1 Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview

6 Intravascular Ultrasound Systems (IVUS) - Recent Developments

6.1 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results
6.2 May 17, 2018: NanoVibronix Provides Business Update for the First Quarter 2018
6.3 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow
6.4 May 07, 2018: Innovative Health Receives FDA Clearance for the ViewFlex Xtra Diagnostic Ultrasound Catheter
6.5 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
6.6 May 01, 2018: Novasight Hybrid System Receives FDA 510(k) Clearance
6.7 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018
6.8 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.9 Apr 02, 2018: NanoVibronix Provides Year-End 2017 Business Update and Files 10-K
6.10 Mar 11, 2018: Infraredx Highlights Value of IVUS + NIRS for Detecting Lipid Core Plaque at the American College of Cardiology 67th Annual Scientific Session
6.11 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017
6.12 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
6.13 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
6.14 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers
6.15 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
6.16 Dec 21, 2017: NanoVibronix CEO Brian Murphy Provides Business Update Letter to Shareholders
6.17 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
6.18 Dec 13, 2017: Terumo Constructs a New Building in Yamaguchi, Japan To Strengthen Production Operations in Interventional Systems
6.19 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results
6.20 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue
6.21 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report
6.22 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017
6.23 Oct 10, 2017: Terumo Provides Update on Impact from Hurricane Maria
6.24 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria
6.25 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
6.26 Sep 26, 2017: MicroVention Celebrates Grand Opening of New Worldwide Innovation Center in Aliso Viejo, California
6.27 Sep 11, 2017: An opportunity to evaluate and speed-up new projects - Meet GE Healthcare at the Uppsala BIO booth
6.28 Aug 22, 2017: Medtronic Reports First Quarter Financial Results
6.29 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017
6.30 Jul 25, 2017: Catherine Estrampes appointed President & CEO of GE Healthcare Europe
6.31 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
6.32 Jun 19, 2017: Conavi Medical Welcomes Peter Wehrly to the Board of Directors
6.33 Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery

7 Appendix

7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables

Table 1: Intravascular Ultrasound Systems (IVUS) - Pipeline Products by Stage of Development
Table 2: Intravascular Ultrasound Systems (IVUS) - Pipeline Products by Segment
Table 3: Intravascular Ultrasound Systems (IVUS) - Pipeline Products by Territory
Table 4: Intravascular Ultrasound Systems (IVUS) - Pipeline Products by Regulatory Path
Table 5: Intravascular Ultrasound Systems (IVUS) - Pipeline Products by Estimated Approval Date
Table 6: Intravascular Ultrasound Systems (IVUS) Companies - Pipeline Products by Stage of Development
Table 7: Intravascular Ultrasound Systems (IVUS) - Pipeline Products by Stage of Development
Table 8: Arbor Ultrasound Technologies, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Carotid Ultrasound Imaging System - Product Status
Table 10: Carotid Ultrasound Imaging System - Product Description
Table 11: Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: 3D Ultrasound Next Generation Catheter - Product Status
Table 13: 3D Ultrasound Next Generation Catheter - Product Description
Table 14: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Intravascular Ultrasound-Imaging Catheter - High Definition - Product Status
Table 16: Intravascular Ultrasound-Imaging Catheter - High Definition - Product Description
Table 17: iSight / MDU5+ - Product Status
Table 18: iSight / MDU5+ - Product Description
Table 19: Covidien plc Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Covidien SeeHawk - Product Status
Table 21: Covidien SeeHawk - Product Description
Table 22: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
Table 23: Catheter-Based Device - Product Status
Table 24: Catheter-Based Device - Product Description
Table 25: North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Intravascular Ultrasound Transducers - Product Status
Table 27: Intravascular Ultrasound Transducers - Product Description
Table 28: OCT Medical Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 29: IVUS - OCT Imaging System - Product Status
Table 30: IVUS - OCT Imaging System - Product Description
Table 31: RadioSon Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Intravascular Ultrasound-Imaging Catheter - Product Status
Table 33: Intravascular Ultrasound-Imaging Catheter - Product Description
Table 34: SIBUS Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Intravascular Ultrasound Imaging System - Product Status
Table 36: Intravascular Ultrasound Imaging System - Product Description
Table 37: Soundpipe LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 38: GUIDE-Tx - Critical Limb Ischemia - Product Status
Table 39: GUIDE-Tx - Critical Limb Ischemia - Product Description
Table 40: GUIDE-Tx - Neointimal Hyperplasia - Product Status
Table 41: GUIDE-Tx - Neointimal Hyperplasia - Product Description
Table 42: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 43: IVUS - Product Status
Table 44: IVUS - Product Description
Table 45: University of Oxford Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Intravascular Imaging Catheter - Product Status
Table 47: Intravascular Imaging Catheter - Product Description
Table 48: University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview
Table 49: Photoacoustic Imaging Device - Cardiovascular Plaque - Product Status
Table 50: Photoacoustic Imaging Device - Cardiovascular Plaque - Product Description
Table 51: Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 52: Focused Acoustic Computed Tomography System - Product Status
Table 53: Focused Acoustic Computed Tomography System - Product Description
Table 54: GIVUS - Product Status
Table 55: GIVUS - Product Description
Table 56: Mackinaw - Product Status
Table 57: Mackinaw - Product Description
Table 58: Next Generation Revolution Catheter - Product Status
Table 59: Next Generation Revolution Catheter - Product Description
Table 60: Preview Second Generation Forward Looking IVUS Catheter And System - Product Status
Table 61: Preview Second Generation Forward Looking IVUS Catheter And System - Product Description
Table 62: Preview Third Generation FL.IVUS Platform - Product Status
Table 63: Preview Third Generation FL.IVUS Platform - Product Description
Table 64: PV IVUS Co-Reg - Product Status
Table 65: PV IVUS Co-Reg - Product Description
Table 66: Glossary

List of Figures

Figure 1: Intravascular Ultrasound Systems (IVUS) - Pipeline Products by Stage of Development
Figure 2: Intravascular Ultrasound Systems (IVUS) - Pipeline Products by Segment
Figure 3: Intravascular Ultrasound Systems (IVUS) - Pipeline Products by Territory
Figure 4: Intravascular Ultrasound Systems (IVUS) - Pipeline Products by Regulatory Path
Figure 5: Intravascular Ultrasound Systems (IVUS) - Pipeline Products by Estimated Approval Date